Alpha 2.0
Login Register
» Articles » PMID: 10983209

Autoimmune Diseases: a Leading Cause of Death Among Young and Middle-aged Women in the United States

Overview
Journal Am J Public Health
Specialty Public Health
Date 2000 Sep 13
PMID 10983209
Citations 99
Authors
S J Walsh
L M Rau
Affiliations
Soon will be listed here.
Abstract

Objectives: This study assessed the effect of autoimmune diseases on mortality among women.

Methods: Counts of autoimmune disease deaths were compared with frequencies of the 10 "official" leading causes of death among women in the United States in 1995.

Results: Autoimmune disease deaths exceeded the frequency of the 10th leading cause in every age category of women younger than 65 years and exceeded that for the eighth leading cause in the 15 to 24, 25 to 44, and 45 to 64 years age groups.

Conclusions: Autoimmune diseases constitute a leading cause of death among young and middle-aged women. This fact is obscured by current methods used to identify leading causes.

Citing Articles

Association between infertility and incident onset of systemic autoimmune rheumatic disease after childbirth: a population-based cohort study.

Scime N, Velez M, Choi M, Ray J, Boblitz A, Brown H Hum Reprod. 2024; 40(1):157-166.

PMID: 39656875 PMC: 11700898. DOI: 10.1093/humrep/deae253.

Can eye-tracking help to create a new method for X-ray analysis of rheumatoid arthritis patients, including joint segmentation and scoring methods?.

Quere B, Meneur L, Foulquier N, Pensec H, Devauchelle-Pensec V, Garrigues F PLOS Digit Health. 2024; 3(10):e0000616.

PMID: 39374482 PMC: 11458192. DOI: 10.1371/journal.pdig.0000616.

Sex difference in human diseases: mechanistic insights and clinical implications.

Shi Y, Ma J, Li S, Liu C, Liu Y, Chen J Signal Transduct Target Ther. 2024; 9(1):238.

PMID: 39256355 PMC: 11387494. DOI: 10.1038/s41392-024-01929-7.

Pregnancy complications and new-onset maternal autoimmune disease.

Scime N, Grandi S, Ray J, Dennis C, De Vera M, Banack H Int J Epidemiol. 2024; 53(5).

PMID: 39191479 PMC: 11349189. DOI: 10.1093/ije/dyae115.

Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus.

Samavati S, Yarani R, Kiani S, Hoseinkhani Z, Mehrabi M, Levitte S J Inflamm (Lond). 2024; 21(1):20.

PMID: 38867277 PMC: 11170788. DOI: 10.1186/s12950-024-00381-2.

References
1.
MASI A, DAngelo W . Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. Ann Intern Med. 1967; 66(5):870-83. DOI: 10.7326/0003-4819-66-5-870. View
2.
ATWATER E, Jacox R . The death certificate in rheumatoid arthritis. Arthritis Rheum. 1967; 10(3):259. DOI: 10.1002/art.1780100313. View
3.
Allebeck P, Ahlbom A, Allander E . Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol. 1981; 10(4):301-6. DOI: 10.3109/03009748109095320. View
4.
Gardner P, Rosenberg H, Wilson R . Leading causes of death by age, sex, race, and Hispanic origin: United States, 1992. Vital Health Stat 20. 1996; (29):1-94. View
5.
Friede A, Reid J, Ory H . CDC WONDER: a comprehensive on-line public health information system of the Centers for Disease Control and Prevention. Am J Public Health. 1993; 83(9):1289-94. PMC: 1694976. DOI: 10.2105/ajph.83.9.1289. View